Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-06-023075
Filing Date
2006-04-06
Accepted
2006-04-06 16:34:14
Documents
6
Period of Report
2006-02-28

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT PURSUANT TO SECTIONS 13 OR 15(D) a06-8278_110q.htm 10-Q 1117485
2 AMENDMENT TO AMENDED AND RESTATED ARTICLES OF INCORPORATION a06-8278_1ex3d3.htm EX-3.3 8384
3 302 CERTIFICATION a06-8278_1ex31d1.htm EX-31.1 13406
4 302 CERTIFICATION a06-8278_1ex31d2.htm EX-31.2 13096
5 906 CERTIFICATION a06-8278_1ex32d1.htm EX-32.1 5381
6 906 CERTIFICATION a06-8278_1ex32d2.htm EX-32.2 5375
  Complete submission text file 0001104659-06-023075.txt   1164562
Mailing Address 3130 GATEWAY DR P O BOX 5625 NORCROSS GA 30091-5625
Business Address 3130 GATWAY PO BOX 5625 NORCROSS GA 30091 770 441 2051
IMMUCOR INC (Filer) CIK: 0000736822 (see all company filings)

EIN.: 222408354 | State of Incorp.: GA | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-14820 | Film No.: 06745486
SIC: 2835 In Vitro & In Vivo Diagnostic Substances